CCA
PBYI icon

Checchi Capital Advisers’s Puma Biotechnology PBYI Stock Holding History

Checchi Capital Advisers’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-101
Closed -$3K – 973
2016
Q2 		$3K Hold
101
– – ﹤0.01% 1476
2016
Q1 		$3K Buy
+101
New +$4.56K ﹤0.01% 1487

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Checchi Capital Advisers's PBYI Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Puma Biotechnology (PBYI) in Q3 2016, closing a stake of 101 shares — an estimated $3K sold.

Checchi Capital Advisers first reported a position in PBYI in Q1 2016 and held it in 2 quarters. The position peaked at $3K in Q2 2016. 149 funds tracked by Wall St. Rank hold PBYI as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Puma Biotechnology position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 101 Puma Biotechnology shares in Q3 2016, an estimated $3K.
  • Checchi Capital Advisers first reported a position in Puma Biotechnology in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Puma Biotechnology position peaked at $3K in Q2 2016.
  • 149 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.